Oxidation of reduced nicotinamide-adenine dinucleotide in muscle homogenates [PDF]
Alfredo Margreth, Azzone Gf
openalex +1 more source
An Ultrasensitive Assay of Nicotinamide Adenine Dinucleotide
openaire +3 more sources
Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies
Targeting lung various cells to alleviate pneumoconiosis by suppressing ferroptosis. AAV9‐HGF, adeno‐associated virus‐hepatocyte growth factor; DFP, deferiprone; DHQ, dihydroquercetin; Fer‐1, ferrostatin‐1; IL‐1β, interleukin‐1β; NMN, nicotinamide mononucleotide; sh‐SLC39A14, shRNA targeting solute carrier family 39 member 14; si‐OC‐STAMP, siRNA ...
Mengli Yan+4 more
wiley +1 more source
Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients. [PDF]
Guan Z, Gu X, Zheng L.
europepmc +1 more source
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors. [PDF]
She J, Sheng R, Qin ZH.
europepmc +1 more source
Metabolism and Congenital Malformations — NAD’s Effects on Development [PDF]
Vander Heiden, Matthew G.
core +1 more source
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian+2 more
wiley +1 more source
Oral MIB-626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID-19 and Acute Kidney Injury: A Randomized Controlled Trial. [PDF]
Pencina KM+15 more
europepmc +1 more source
Nicotinamide Adenine Dinucleotide in the Treatment of Chronic Schizophrenic Patients [PDF]
Axel Hoffer, H Osmond
openalex +1 more source